Search results for "Malalties del fetge"

showing 2 items of 2 documents

Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trial.

2018

Summary Background & aims To assess the possible association between a validated Dietary Inflammatory Index (DII) and specific dietary components with suitable non-invasive markers of liver status in overweight and obese subjects within the PREDIMED study. Methods A cross-sectional study encompassing 794 randomized overweight and obese participants (mean ± SD age: 67.0 ± 5.0 y, 55% females) from the PREDIMED (PREvencion con DIeta MEDiterranea) trial was conducted. DII is a validated tool evaluating the effect of diet on six inflammatory biomarkers (IL-1b, IL-4, IL-6, IL-10, TNF-α and C-reactive protein). Furthermore, a validated 137-item food-frequency-questionnaire was used to obtain the i…

MaleMediterranean dietPhysiologyDiseaseFetge -- MalaltiesOverweightCritical Care and Intensive Care MedicineDiet Mediterranean0302 clinical medicineNon-alcoholic Fatty Liver DiseaseSurveys and QuestionnairesAdiposityNutrition and DieteticsMalalties del fetgeFatty liverMiddle AgedInflamacióDiet RecordsC-Reactive ProteinLiver030220 oncology & carcinogenesisObesitatDieta030211 gastroenterology & hepatologyFemalemedicine.symptommedicine.medical_specialtyInflammation03 medical and health sciencesInternal medicineNAFLDmedicineHumansObesityLiver diseasesAgedInflammationbusiness.industryTumor Necrosis Factor-alphaInterleukinsAdipose tissuesAnthropometryOverweightmedicine.diseasePredimedObesityDietTeixit adipósEndocrinologyCross-Sectional StudiesPatient CompliancebusinessBiomarkers
researchProduct

Modeling NAFLD Disease Burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

2018

Background & Aims: Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are increasingly a cause of cirrhosis and hepatocellular carcinoma globally. This burden is expected to increase as epidemics of obesity, diabetes and metabolic syndrome continue to grow. The goal of this analysis was to use a Markov model to forecast NAFLD disease burden using currently available data. Methods: A model was used to estimate NAFLD and NASH disease progression in eight countries based on data for adult prevalence of obesity and type 2 diabetes mellitus (DM). Published estimates and expert consensus were used to build and validate the model projections. Results: If obesity and…

Time FactorsDiseaseddc:616.07Liver disease0302 clinical medicineDiabetes mellitusCost of IllnessNon-alcoholic Fatty Liver DiseasePrevalenceHCCddc:616Mathematical modelseducation.field_of_studyMalalties del fetgeLiver DiseasesFatty liverBurden of diseaseNASHCardiovascular diseaseMetabolic syndromeMarkov ChainsCirrhosis030220 oncology & carcinogenesis030211 gastroenterology & hepatologyHealth care resource utilizationDiabetes mellituChinaPopulationdigestive system03 medical and health sciencesEnvironmental healthNAFLDmedicineHumansddc:610ObesityeducationDisease burdenCirrhosiHepatologybusiness.industryModels matemàticsnutritional and metabolic diseasesModels Theoreticalmedicine.diseaseObesitydigestive system diseasesDiabetes Mellitus Type 2SteatohepatitisMetabolic syndromebusiness
researchProduct